首页 | 本学科首页   官方微博 | 高级检索  
   检索      


Thiazolidinedione derivatives as PTP1B inhibitors with antihyperglycemic and antiobesity effects
Authors:Bharat Raj Bhattarai  Bhooshan Kafle  Ji-Sun Hwang  Deegendra Khadka  Sun-Myung Lee  Jae-Seung Kang  Seung Wook Ham  Inn-Oc Han  Hwangseo Park  Hyeongjin Cho
Institution:1. Department of Chemistry, Inha University, Incheon 402-751, Republic of Korea;2. Department of Physiology and Biophysics, College of Medicine, Inha University, Incheon 402-751, Republic of Korea;3. Department of Microbiology, College of Medicine, Inha University, Incheon 402-751, Republic of Korea;4. Department of Chemistry, Chung Ang University, Seoul 156-756, Republic of Korea;5. Department of Bioscience and Biotechnology, Sejong University, Seoul 143-747, Republic of Korea
Abstract:Benzylidene-2,4-thiazolidinedione derivatives with substitutions on the phenyl ring at the ortho or para positions of the thiazolidinedione (TZD) group were synthesized as PTP1B inhibitors with IC50 values in a low micromolar range. Compound 3e, the lowest, bore an IC50 of 5.0 μM. In vivo efficacy of 3e as an antiobesity and hypoglycemic agent was evaluated in a mouse model system. Significant improvement of glucose tolerance was observed. This compound also significantly suppressed weight gain and significantly improved blood parameters such as TG, total cholesterol and NEFA. Compound 3e was also found to activate peroxisome proliferator-activated receptors (PPARs) indicating multiple mechanisms of action.
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号